Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled Trial

Mise à jour : Il y a 4 ans
Référence : NCT00718679

Femme et Homme

  • | Pays :
  • Switzerland
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study is placebo controlled, double blind, randomised, two arm dose escalation of a new product for specific immunotherapy in cat allergic patients


Critère d'inclusion

  • Allergy to Cat Dander

Liens